Minnesota regulators have released a shopping list, of sorts, for medical cannabis patients.
In Guidance Memo GM-2026-08, published Monday, the Office of Cannabis Management named four categories of "high medical need" products that businesses with a medical cannabis retail endorsement must carry starting January 1, 2027, The Marijuana Herald reports:
- CBD-only products, in both swallowed and mouth-absorbed forms like tinctures
- High-CBD products with a THC-to-CBD ratio of at least 1:15
- Balanced 1:1 THC-to-CBD products, in pills, oral solutions and tinctures or dissolvables
- At least one high-THC product with 20 mg or more of THC per serving
Manufacturers with medical endorsements will have to produce these items. None of these product types are currently approved for recreational sale, so only medical-endorsed businesses can make and sell them. Regulators said the list reflects feedback from patients, caregivers, practitioners and businesses, plus purchasing patterns and complaints about availability.
Under the new law, the state can take action against businesses that fail to make a required product available within 24 hours of a patient's request, with penalties up to suspension or revocation of a medical endorsement.
What it means for travelers: if you're visiting as a 21+ adult-use shopper, this list mostly won't touch you, since these products are medical-only. Registered patients should see steadier access to these formulas in the new year.






